A neurofibroma is a type of peripheral nerve tumor that forms a soft bump on or under the skin. The tumor can develop within a major or minor nerve anywhere in the body.

This common type of nerve tumor tends to form centrally within the nerve. A neurofibroma forms on the protective covering of the nerve, known as the nerve sheath. Sometimes it grows on several nerve bundles. When this happens, it’s called a plexiform neurofibroma.

 

A neurofibroma may cause mild symptoms or no symptoms at all. If the tumor presses against nerves or grows within them, it may cause pain or numbness.

A neurofibroma usually isn’t cancer. Rarely, it can become cancer.

A neurofibroma might cause no symptoms. If symptoms occur, they’re usually mild. When a neurofibroma grows on or under the skin, symptoms may include:

  • A bump on the skin. The bump may be the color of your skin or pink or tan.
  • Pain.
  • Bleeding.

If a neurofibroma becomes large or presses against or grows on a nerve, symptoms may include:

  • Pain.
  • Tingling.
  • Numbness or weakness.
  • Change in appearance when a large neurofibroma is on the face.

Some people with neurofibromas have a genetic condition known as neurofibromatosis type 1 (NF1). A person with NF1 may have many neurofibromas. The number of neurofibromas increases with age.

A tumor that involves many nerves, known as a plexiform neurofibroma, can occur in a person with NF1. This type of neurofibroma can grow large and cause pain. It also can become cancerous.

A neurofibroma can arise with no known cause, or it may appear in people with a genetic condition called neurofibromatosis type 1. Neurofibromas most often are found in people ages 20 to 30 years old.

The only known risk factor for neurofibromas is having the genetic condition known as neurofibromatosis type 1 (NF1). People with NF1 have several neurofibromas, along with other symptoms. In about half of the people with NF1, the disease was passed down from a parent. However, most people with neurofibromas don’t have NF1.

 

 

To diagnose a neurofibroma, your healthcare professional gives you a physical exam and reviews your medical history.

You may need an imaging test such as a CT or MRI scan. Imaging can help find the location of the tumor. CT and MRI also can find very small tumors and show what tissues are affected. A PET scan can reveal whether the tumor is cancer. A tumor that’s not cancerous is known as benign.

A sample of the neurofibroma may be taken and tested for diagnosis. This is known as a biopsy. A biopsy also may be needed if surgery is being considered as a treatment.

Neurofibroma treatment isn’t needed for a single tumor with no symptoms. Healthcare professionals usually monitor the neurofibroma. Surgery may be needed if the tumor is causing symptoms or for cosmetic reasons. Treatment may include:

  • Monitoring. Your healthcare professional may recommend observation of a small neurofibroma that causes no symptoms. Monitoring also may be recommended if the neurofibroma causes symptoms but is located in an area that makes it hard to remove. Observation includes regular checkups and imaging tests to see if the tumor is growing.
  • Medicine to treat a plexiform neurofibroma. Selumetinib (Koselugo) has been approved to treat a plexiform neurofibroma in children with neurofibromatosis type 1. A plexiform neurofibroma grows on many nerves. The medicine can shrink the tumor.
  • Surgery to remove the tumor. Symptoms can be relieved by removing all or part of a neurofibroma that’s pressing on nearby tissue or damaging organs. The type of surgery depends on the location and size of the tumor. The type of surgery also depends on whether the neurofibroma is intertwined with more than one nerve. The goal of surgery is to remove as much of the tumor as possible without causing further nerve damage.

    After surgery, you may need physical rehabilitation. Physical therapists and occupational therapists can guide you through exercises that keep your muscles and joints active. Rehabilitation also helps prevent stiffness and restore your function and feeling.

  • Clinical trials. You may qualify for a clinical trial testing an experimental treatment.

It’s a good idea to prepare for your appointment to make the most of your time with your healthcare professional.

What you can do

  • Write down details of your symptoms, including any triggers that may have caused you to faint.
  • Make a list of all medicines, vitamins and supplements you’re taking.
  • Write down questions you want to ask, including questions about potential tests and treatments.

What to expect from your doctor

Questions your healthcare professional might ask include:

  • What were you doing just before you fainted?
  • What symptoms, if any, did you experience before you fainted?
  • Have you ever fainted before? If yes, what were you doing before you fainted then?
  • Have you recently started taking a new medicine?
  • Have you ever had a head injury?
  • Has anyone in your family died suddenly of a heart condition?
  1. Gilchrist JM, et al. Peripheral nerve tumors. https://www.uptodate.com/contents/search. Accessed June 3, 2024.
  2. Resnick D, et al., eds. Neurofibromatosis, fibrous dysplasia and tuberous sclerosis. In: Resnick’s Bone and Joint Imaging. 4th ed. Elsevier; 2025. https://www.clinicalkey.com. Accessed June 3, 2024.
  3. Neurofibromatosis. Merck Manual Professional Version. https://www.merckmanuals.com/professional/SearchResults?query=neurofibromatosis. Accessed June 3, 2024.
  4. Winn HR, ed. Benign and malignant tumors of the peripheral nerve. In: Youmans and Winn Neurological Surgery. 8th ed. Elsevier; 2023. https://www.clinicalkey.com. Accessed June 3, 2024.
  5. Jankovic J, et al., eds. Primary nervous system tumors in adults. In: Bradley and Daroff’s Neurology in Clinical Practice. 8th ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed Sept. 23, 2022.
  6. Goldman L, et al., eds. Tumors of the central nervous system. In: Goldman-Cecil Medicine. 27th ed. Elsevier; 2024. https://www.clinicalkey.com. Accessed June 3, 2024.
  7. Ly I, et al. Target product profile for cutaneous neurofibromas: Clinical trials to prevent, arrest or regress cutaneous neurofibromas. Journal of Investigative Dermatology. 2023; doi:10.1016/j.jid.2023.01.041.
  8. Saleh M, et al. Neurofibromatosis type 1 system-based manifestations and treatments: A review. Neurological Sciences. 2023; doi:10.1007/s10072-023-06680-5.
  9. Carlos-Escalante JA, et al. Primary benign tumors of the spinal canal. World Neurosurgery. 2022; doi:10.1016/j.wneu.2022.04.135.
mobile

Ad

Women have unique health issues. And some of the health issues that affect both men and women can affect women differently.

Book your appointment TODAY!

Search on the closest Doctor to your location and book based on specialty. EARN 10 POINTS more with CuraPOINT.

BOOK
Edit Template